Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng-Eong Ooi

Showing results (11-20 of 285) with videos related to

Pageof 29
Sort By:
Science Translational Medicine|July 12, 2023
Insights into dengue immunity from vaccine trialsEng Eong Ooi, Shirin Kalimuddin
Nature Immunology|February 22, 2022
A potential silver lining of delaying the second doseDavid R Martinez, Eng Eong Ooi
Annals of the Academy of Medicine, Singapore|December 21, 2013
Molecular biomarkers at the interface of basic and clinical dengue researchYie Hou Lee, Eng Eong Ooi
Elife|February 15, 2024
Race against dengueSwee Sen Kwek, Eng Eong Ooi
The Lancet. Infectious Diseases|June 30, 2023
Inactivated Zika virus vaccine and the complexity of flavivirus antigenicityJenny G Low, Eng Eong Ooi
The Lancet. Infectious Diseases|February 26, 2024
Is a therapeutic dengue monoclonal antibody on the way?Eng Eong Ooi, Yvonne Fz Chan
Science (New York, N.Y.)|June 4, 2021
Antibody sugars are bittersweetRuklanthi de Alwis, Eng Eong Ooi
Cadernos De Saude Publica|March 17, 2009
Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease preventionEng-Eong Ooi, Duane J Gubler
Expert Review of Anti-Infective Therapy|October 4, 2012
Diagnosis of dengue: an updateKin Fai Tang, Eng Eong Ooi
The Lancet. Infectious Diseases|October 1, 2022
Externalities modulate the effectiveness of the Wolbachia release programmeEng Eong Ooi, Annelies Wilder-Smith
Pageof 29

Showing results (11-20 of 285) with videos related to

Sort By:
Pageof 29
Science Translational Medicine|July 12, 2023
Insights into dengue immunity from vaccine trialsEng Eong Ooi, Shirin Kalimuddin
Nature Immunology|February 22, 2022
A potential silver lining of delaying the second doseDavid R Martinez, Eng Eong Ooi
Annals of the Academy of Medicine, Singapore|December 21, 2013
Molecular biomarkers at the interface of basic and clinical dengue researchYie Hou Lee, Eng Eong Ooi
Elife|February 15, 2024
Race against dengueSwee Sen Kwek, Eng Eong Ooi
The Lancet. Infectious Diseases|June 30, 2023
Inactivated Zika virus vaccine and the complexity of flavivirus antigenicityJenny G Low, Eng Eong Ooi
The Lancet. Infectious Diseases|February 26, 2024
Is a therapeutic dengue monoclonal antibody on the way?Eng Eong Ooi, Yvonne Fz Chan
Science (New York, N.Y.)|June 4, 2021
Antibody sugars are bittersweetRuklanthi de Alwis, Eng Eong Ooi
Cadernos De Saude Publica|March 17, 2009
Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease preventionEng-Eong Ooi, Duane J Gubler
Expert Review of Anti-Infective Therapy|October 4, 2012
Diagnosis of dengue: an updateKin Fai Tang, Eng Eong Ooi
The Lancet. Infectious Diseases|October 1, 2022
Externalities modulate the effectiveness of the Wolbachia release programmeEng Eong Ooi, Annelies Wilder-Smith
Pageof 29